Mavrilimumab (CAM 3001) is a monoclonal antibody with antiviral activity that has an affinity for the alpha subunit of the granulocytic-macrophage colony-stimulating factor (GM-CSF) receptor and blocks downstream intracellular signaling of GM-CSF. GM-CSF may
CAS Number:
[1085337-57-0]
Target:
CSF-1R|||Virus Protease
* VAT and and shipping costs not included. Errors and price changes excepted